Advanced Cell Technology, Inc., received FDA approval for starting Phase I/II clinical trial to use stem cells for the treatment of Stargardt’s disease. Stargardt’s disease is an inherited type of macular degeneration affecting individuals at age 10-20. There is no cure.
Similar to other macular diseases, the photoreceptors, and the layer of cells just beneath, call the retinal pigment epithelium (RPE), become destr (Read more...)